Serum Leptin Receptor and the rs1137101 Variant of the LEPR Gene Are Associated with Bladder Cancer
Biomolecules · 2023
DOI: 10.3390/biom13101498 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Mahmoud A Alfaqih und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Medicine and Medical Sciences, Arabian Gulf University, Manama 15503, Bahrain. Hauptthemen laut MEDLINE: Leptin, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Research at Jordan University of Science and Technology.
Abstract (Originalsprache)
Globally, bladder cancer (BC) is one of the ten most common tumors. Obesity is a worldwide problem associated with an increased BC risk. Considering that levels of leptin and/or its receptor are often deregulated in obese individuals, we hypothesized that they could contribute to BC. To test this hypothesis, we utilized a case-control study in which 116 patients with a confirmed diagnosis of BC and 116 controls were recruited. The serum levels of leptin and leptin receptor were measured. Patients and controls were also genotyped for SNPs in the LEP (rs7799039, rs791620, and rs2167270) and LEPR genes (rs1137100, rs1137101, and rs1805094). The univariate analysis indicated that BC patients had significantly higher levels of leptin and lower levels of leptin receptor (p < 0.05). Moreover, rs7799039 of LEP and rs1137101 of LEPR were associated with BC (p < 0.05). In the multivariate analysis, leptin receptor levels were protective (OR: 0.98, 95% CI = 0.97–0.99, p = 0.002) while the GG genotype of rs1137101 of LEPR increased BC risk (OR: 3.42, 95% CI = 1.27–9.20, p = 0.02). These findings highlight that lifestyle changes could be useful in preventing BC and that disturbances in energy metabolism could play a role in the pathobiology of BC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, College of Medicine and Medical Sciences, Arabian Gulf University, Manama 15503, Bahrain.
- Department of Physiology and Biochemistry, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
- Department of Pharmacology, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
- Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
ORCID-Profile: Mahmoud A Alfaqih, Lina Elsalem, Yousef Khader, Ebaa Ababneh
Förderung
- Deanship of Research at Jordan University of Science and Technology
Zitieren
APA
Alfaqih, M. A., Elsalem, L., Nusier, M., Mhedat, K., Khader, Y., & Ababneh, E. (2023). Serum Leptin Receptor and the rs1137101 Variant of the LEPR Gene Are Associated with Bladder Cancer. Biomolecules. https://doi.org/10.3390/biom13101498
Vancouver
Alfaqih MA, Elsalem L, Nusier M, Mhedat K, Khader Y, Ababneh E. Serum Leptin Receptor and the rs1137101 Variant of the LEPR Gene Are Associated with Bladder Cancer. Biomolecules. 2023. doi:10.3390/biom13101498
BibTeX
@article{Alfaqih2023,
author = {Alfaqih, Mahmoud A and Elsalem, Lina and Nusier, Mohamad and Mhedat, Khawla and Khader, Yousef and Ababneh, Ebaa},
title = {Serum Leptin Receptor and the rs1137101 Variant of the LEPR Gene Are Associated with Bladder Cancer},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13101498}
}
EUVIMED